Investigation Overview
An investigation on behalf of investors in shares of United Therapeutics Corporation (NASDAQ:UTHR) was announced over potential breaches of fiduciary duties by certain officers and directors at United Therapeutics. The investigation by a law firm concerns whether certain United Therapeutics Corporation officers and directors breached their fiduciary duties and caused damage to the co...
You must register (for free) or login to view the entire investigation.